respiR8 consists of a consumable oxygen mask, fitted with Anaxsys’ patented sensor which measures each breath, and a small electronic monitor that captures, displays and records the patients’ continuous respiratory rate, the company claimed.

The patients’ respiratory rate can be viewed in either real-time numeric breaths per minute display or trending display on the monitor’s easy to read AMOLED screen.

Anaxsys CEO Deryk Williams said that respiR8 has been developed to address the clinical need for more accurate monitoring of respiration rate in clinical environments such as perioperative, and is intended for use on patients requiring supplemental oxygen via a face mask.

“The use of respiR8 provides more accurate information of a patient’s respiratory rate than existing clinical practice of manually counting chest excursions and its novel sensor measures continuous respiratory rate unlike any other respiratory device currently available on the market,” Williams said.